194 related articles for article (PubMed ID: 26723894)
1. Challenges in profiling and lead optimization of drug discovery for methyltransferases.
Horiuchi KY
Drug Discov Today Technol; 2015 Nov; 18():62-8. PubMed ID: 26723894
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in developing selective inhibitors of protein methyltransferases.
Kaniskan HÜ; Jin J
Curr Opin Chem Biol; 2017 Aug; 39():100-108. PubMed ID: 28662389
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
Verma SK; Knight SD
Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
[TBL] [Abstract][Full Text] [Related]
4. Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors.
Liao D
Drug Discov Today Technol; 2015 Nov; 18():24-8. PubMed ID: 26723889
[TBL] [Abstract][Full Text] [Related]
5. Optimization of High-Throughput Methyltransferase Assays for the Discovery of Small Molecule Inhibitors.
Dong G; Yasgar A; Peterson DL; Zakharov A; Talley D; Cheng KC; Jadhav A; Simeonov A; Huang R
ACS Comb Sci; 2020 Aug; 22(8):422-432. PubMed ID: 32525297
[TBL] [Abstract][Full Text] [Related]
6. A high throughput scintillation proximity imaging assay for protein methyltransferases.
Ibanez G; Shum D; Blum G; Bhinder B; Radu C; Antczak C; Luo M; Djaballah H
Comb Chem High Throughput Screen; 2012 Jun; 15(5):359-71. PubMed ID: 22256970
[TBL] [Abstract][Full Text] [Related]
7. Cancer treatment of the future: inhibitors of histone methyltransferases.
Spannhoff A; Sippl W; Jung M
Int J Biochem Cell Biol; 2009 Jan; 41(1):4-11. PubMed ID: 18773966
[TBL] [Abstract][Full Text] [Related]
8. Structure-guided DOT1L probe optimization by label-free ligand displacement.
Yi JS; Federation AJ; Qi J; Dhe-Paganon S; Hadler M; Xu X; St Pierre R; Varca AC; Wu L; Marineau JJ; Smith WB; Souza A; Chory EJ; Armstrong SA; Bradner JE
ACS Chem Biol; 2015 Mar; 10(3):667-74. PubMed ID: 25397901
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Protein Methyltransferases and Demethylases.
Kaniskan HÜ; Martini ML; Jin J
Chem Rev; 2018 Feb; 118(3):989-1068. PubMed ID: 28338320
[TBL] [Abstract][Full Text] [Related]
10. Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.
Hui M; Jian Z; Peiyuan Z; Zhenwei W; Huibin Z
Future Med Chem; 2018 Apr; 10(8):895-906. PubMed ID: 29620420
[TBL] [Abstract][Full Text] [Related]
11. GPCR profiling: from hits to leads and from genotype to phenotype.
Cvijic ME; Sum CS; Alt A; Zhang L
Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
[TBL] [Abstract][Full Text] [Related]
12. Improving understanding of chromatin regulatory proteins and potential implications for drug discovery.
Rafehi H; Khan AW; El-Osta A
Expert Rev Proteomics; 2016; 13(4):435-45. PubMed ID: 26923902
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic drug target deconvolution by mass spectrometry-based technologies.
Noberini R; Bonaldi T
Nat Struct Mol Biol; 2019 Oct; 26(10):854-857. PubMed ID: 31582842
[TBL] [Abstract][Full Text] [Related]
14. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
[TBL] [Abstract][Full Text] [Related]
16. Development and application of PI3K assays for novel drug discovery.
Yanamandra M; Mitra S; Giri A
Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
[TBL] [Abstract][Full Text] [Related]
17. In Situ Proteome Profiling and Bioimaging Applications of Small-Molecule Affinity-Based Probes Derived From DOT1L Inhibitors.
Zhu B; Zhang H; Pan S; Wang C; Ge J; Lee JS; Yao SQ
Chemistry; 2016 Jun; 22(23):7824-36. PubMed ID: 27115831
[TBL] [Abstract][Full Text] [Related]
18. A chemical biology toolbox to study protein methyltransferases and epigenetic signaling.
Scheer S; Ackloo S; Medina TS; Schapira M; Li F; Ward JA; Lewis AM; Northrop JP; Richardson PL; Kaniskan HÜ; Shen Y; Liu J; Smil D; McLeod D; Zepeda-Velazquez CA; Luo M; Jin J; Barsyte-Lovejoy D; Huber KVM; De Carvalho DD; Vedadi M; Zaph C; Brown PJ; Arrowsmith CH
Nat Commun; 2019 Jan; 10(1):19. PubMed ID: 30604761
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of protein methyltransferases as chemical tools.
Luo M
Epigenomics; 2015; 7(8):1327-38. PubMed ID: 26646500
[TBL] [Abstract][Full Text] [Related]
20. Assay development for histone methyltransferases.
Horiuchi KY; Eason MM; Ferry JJ; Planck JL; Walsh CP; Smith RF; Howitz KT; Ma H
Assay Drug Dev Technol; 2013 May; 11(4):227-36. PubMed ID: 23557020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
